Clinical Trials Browser

Has results × Neoplasms × Lenalidomide × Clear all

NCT01348919 2023-06-28

Delanzomib (CEP-18770) in Combination With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

Phase 1/2 Completed

11 enrolled 15 charts

Multiple Myeloma, Neoplasms